Sudarshan Pharma Board Meeting on April 30, 2026

• Board meeting scheduled for April 30, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
• Trading window closure extended until 48 hours after declaration of financial results for compliance.
• Regulatory disclosure made to BSE pursuant to SEBI Listing Regulations Regulation 29 requirements.